argenx SE
$637.60
24H
Market Cap
Volume
Supply
Price Chart
About argenx SE - ARGX.BR
Argenx SE is a biotechnology company that focuses on the development and commercialization of human antibody therapeutics for the treatment of autoimmune diseases and cancer. Their most advanced products are typically derived from their proprietary antibody discovery platform known as the SIMPLE Antibodyâ„¢ Platform.
What are argenx SE's core values and mission statement?
Argenx SE's core values are centered around the principles of innovation, teamwork, and a commitment to improving the lives of patients. Their mission is to harness the power of the immune system to develop novel antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
Who founded argenx SE and when?
argenx SE was founded by Tim Van Hauwermeiren, Hans de Haard, and Torsten Dreier in 2008.
Who leads argenx SE?
As of the last update I have, Tim Van Hauwermeiren is the CEO of argenx SE.
Where is argenx SE located, and what is its base country?
argenx SE is headquartered in the Netherlands.
On which exchanges is argenx SE traded?
argenx SE is traded on the NASDAQ Global Select Market under the ticker symbol ARGX and on the Euronext Brussels under the same ticker.
Historical data
argenx SE (ARGX) Price Live Data
The live price of argenx SE (ARGX) is $637.60, with a trading volume of 10,016 in the last 24 hours. Wrapstocks updates the ARGX price in real-time. argenx SE is up 1.55% in the last 24 hours. The company has a live market cap of $38,126,279,126.72 and a supply of 59,796,295 ARGX stocks.
argenx SE (ARGX) is traded on Euronext Brussels, and currently, the market is closed; trading will be resumed in 1 hour and 10 minutes.
